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Abstract
Background: To investigate whether polymorphism rs540782 on chromsome 1, in close proximity to the Zona
Pellucida Glycoprotein 4 (ZP4) gene, is a risk factor for primary open angle glaucoma (POAG).
Method: The study genotyped 92 unrelated POAG cases and 95 control subjects from Saudi Arabia using
Taq-Man® assay.
Results: The genotype frequency distribution did not deviate significantly from the Hardy-Weinberg equilibrium
(p > 0.05). Overall, both the genotype and allele frequencies were not significantly different between cases and
controls. The minor ‘C’ allele frequency was 49.4%, which was comparable to the Japanese population and higher
than the Indian and Afro-Caribbean populations. Similarly, no significant association was found between genotypes
and systemic diseases and health awareness/behavior domain variables. Importantly, glaucoma specific indices, such
as intraocular pressure, cup/disc ratio and number of anti-glaucoma medication, also showed no statistically significant
effect of genotypes within POAG cases.
Conclusion: Polymorphism rs540782 is not a risk factor for POAG in the Saudi cohort.
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Background
Primary open angle glaucoma (POAG) is largely polygenic
in nature with genetically complex and multifactorial in-
heritance [1]. It is the second most common form of glau-
coma in Saudi Arabia and a leading cause of irreversible
blindness worldwide [2]. Given the complexity and genetic
mutational heterogeneity of POAG, using population-
based genome wide association study (GWAS), several
investigators have identified a number of variants in
multiple loci/genes to be associated with POAG and
related quantitative traits that may contribute to the devel-
opment and/or progression of the disease in various
ethnic groups [3].
In 2009, a GWAS study in a group of Japanese POAG
patients (n = 1575) identified 3 genetic loci consisting of
six single nucleotide polymorphisms (SNPs) to be associ-
ated with POAG. Of these, 4 intergenic SNPs including
rs540782, located on chromosome 1 flanking the Zona
Pellucida Glycoprotein 4 (ZP4) gene were found to be in
strong linkage [4]. ZP4 gene is involved in functions re-
lated to fertilization and pre-implantation development
and thus far SNPs and/or mutations in this gene were
reported in association with ovarian diseases [5] and
POAG [4]. Subsequent studies have failed to replicate
this association between rs540782 and POAG in Indian
[6], Afro-Caribbean [7] and Japanese [8] populations.
Besides, the functional relevance of the SNP or the gene
to POAG development is not known.
Despite a high prevalence of POAG in Saudi popu-
lation the role of genetic polymorphisms in the devel-
opment of the disease is still unclear [3]. With the
aim to identify a genetic link and provide further
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validation of this POAG-associated variant in a different
ethnic group, we investigated whether SNP rs540782 is
associated with POAG in the middle-eastern cohort of
Saudi Arabia.
Methods
Study design and population
We conducted a case-control genetic association study.
The study adheres to the tenets of the Declaration of
Helsinki and all participants have signed an informed
consent. The study was approved by the College of
Medicine ethical committee (approval number # 08–
657). Saudi patients with a clinically confirmed diagnosis
of POAG and a matching group of glaucoma free
healthy controls were recruited into the study at King
Abdul-Aziz University Hospital (KAUH) in Riyadh,
Saudi Arabia. We recruited 92 Saudi POAG patients
who satisfied the following strict clinical inclusion cri-
teria for POAG: i) appearance of the disc or retinal
nerve fibre layer e.g. thinning or notching of disc rim,
progressive changes, nerve fibre layer defect; ii) the pres-
ence of characteristic abnormalities in the visual field
(e.g. arcuate scotoma, nasal step, paracentral scotoma,
generalized depression) in the absence of other causes or
explanation; iii) age greater than 20 years at the time of
recruitment and iv) open anterior chamber angles bilat-
erally on gonioscopy. Exclusion criteria included evi-
dence of secondary glaucoma, e.g. pigmentary glaucoma,
uveitic, pseudoexfoliation, or any other form of second-
ary glaucoma, and history of steroid use or ocular
trauma. A second group (n = 95) of healthy Saudi con-
trols free from glaucoma by examination were recruited.
Inclusion criteria for these subjects were age >20 years,
normal intraocular pressure (IOP) [IOP < 21 mmHg
without any anti-glaucoma medication], open angles on
gonioscopy, and normal optic disc on examination.
DNA preparation
DNA from patients and controls was obtained from per-
ipheral blood (7 mL) collected in EDTA tubes from all
participating individuals. Extraction was performed using
the illustra blood genomicPrep Mini Spin kit (GE Health-
care, Buckinghamshire, UK) and stored at –20 °C in ali-
quots until further use. Quantification of extracted DNA
was performed using a NanoDrop ND-2000c spectropho-
tometer (Thermo Scientific, Wilmington, DE, USA).
Genotyping of rs540782 at Chr.1: 237933586 on GRCh38
Subjects were genotyped to determine the rs540782 poly-
morphism using the TaqMan® SNP Genotyping Assay
(Applied Biosystems Inc., Foster City, CA, USA) on ABI
7500 Real-Time PCR System (Applied Biosystems) as de-
scribed previously [9]. For detection of rs540782 poly-
morphism, assay ID: C_8859643_10 was used, Each PCR
reaction was performed in a total volume of 25 μL and
consisted of 1X TaqMan® Genotyping Master Mix
(Applied Biosystems), 1X SNP Genotyping Assay Mix and
20 ng DNA. Each 96-well plate included two no template
controls. Real-time PCR was performed on an ABI 7500
using the recommended conditions consisting of incuba-
tion at 95 °C for 10 min, followed by 40 cycles, denatur-
ation at 92 °C for 15 s and annealing/ extension at 60 °C
for 1 min. The VIC® and 6-carboxy-fluorescein (FAM)
fluorescence levels of the PCR products were measured at
60 °C for 1 min. Analysis of fluorescence using the auto-
mated 2-color allele discrimination software on ABI 7500
showed clear discrimination of both the genotypes on a
two-dimensional graph.
Statistical analysis
The analysis was done using SPSS version 22 (IBM Inc.
Chicago, IIinois, USA). Hardy-Weinberg Equilibrium
(HWE) deviation was tested by Pearson’s Chi2 test. Odds
ratios (OR) were calculated to detect the differences
between cases and controls in terms of genotypes and al-
lele frequencies. The Chi2 test was used to detect any as-
sociation between the different genetic profiles (Fishers
2 × 3 Exact test when indicated). Independent samples t-
test was used to investigate whether there was any
significant different between cases and controls in terms
of continuous variables. Normality testing of continuous
variables was done using Kolmogorov Simrnov test.
One-way ANOVA and Kruskal-Wallis Test were used to
detect the mean difference across the three genotypes
within POAG group. A confidence interval (CI) level
was set to 95% where a corresponding p value threshold
was identified as 0.05 where any output p below 0.05
Table 1 Clinical and demographic characteristics POAG cases
and controls
Variables Controls
(n = 95)
No. (%)
Cases
(n = 92)
No. (%)
p valuea
Demographic Characteristics
Age in years, Mean (±SD) 57.2 (13.5) 60.7 (12.3) 0.065*
Male 69 (72.6) 56 (60.8) 0.120
Female 26 (27.3) 36 (39.1) -
Systemic Diseases
Diabetes mellitus 45 (47.3) 49 (53.2) 0.465
Coronary artery disease 6 (6.3) 7 (7.6) 0.780
Hypertension 44 (46.3) 48 (52.1) 0.465
Hypercholesterolemia 9 (9.4) 15 (16.3) 0.192
Health Awareness/Behavior
Family history of glaucoma 4 (4.2) 14 (15.2) 0.012
Smoking 41 (43.1) 34 (36.9) 0.456
aChi2 test
*t-test
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would be interpreted as an indicator of statistical
significant.
Results
Demographic distribution
As shown in Table 1, the control subjects with a mean
age of 57.0 years were found to be slightly younger than
the cases with a mean age of 60.7 years, but this was
found to be non-significant. The study groups showed a
preponderance of male subjects with no statistically sig-
nificant gender distribution. Besides, except for the fam-
ily history of glaucoma (p = 0.012), both the cases and
control groups were found to be similar for systemic co-
morbidities, smoking habit and glaucoma specific clin-
ical indices.
Genotype and allele frequency
The SNP did not deviate significantly from the HWE
(p > 0.05) in both the cases and control groups. Basic al-
lelic testing showed that the allele frequency distribution
was non-significant between the two groups (OR = 1.11;
95% CI = 0.74–1.67; p = 0.606). The minor “C” allele fre-
quency was found to be 0.46 and 0.49 among POAG
cases and controls, respectively. The wild type (G/G)
genotype was detected in 26.3% controls as compared to
23.9% in cases. Besides, the heterozygous C/G genotypes
was observed in 48.4% controls as compared to 58.7%
cases and the homozygous mutant C/C genotype in
25.2% and 17.4% of controls and cases, respectively.
However, association testing for SNP rs540782 between
cases and controls revealed no significant genotype
distribution under additive (Chi2 = 2.38, df = 2, p = 0.30),
dominant (p = 0.70) and recessive models (p = 0.69)
(Table 2).
Table 2 Association results of SNP rs540782 with genotype and
allele frequency distribution in POAG and controls
SNP (Gene) rs540782 (ZP4)
Allelic analysis Controls
(n = 95)
No. (%)
POAG
(n = 92)
No. (%)
Odds ratio 95%
confidence
interval
p valuea
G 96 (50.5) 98 (53.2) 1 Reference -
C* 94 (49.4) 86 (46.7) 1.11 0.74–1.67 0.60
HWE P 0.76 0.09 - - -
Genotype and Model analysis
G/G 25 (26.3) 22 (23.9) 1 Reference -
C/G 46 (48.4) 54 (58.7) 0.75 0.37–1.50 0.48
C/C 24 (25.2) 16 (17.4) 1.32 0.56–3.09 0.66
Additive (Trend) - - - - 0.30§
Dominant - - 0.88 0.45–1.70 0.70
Recessive - - 1.16 0.54–2.0 0.69
aChi2 test
*Risk variant
HWE P Hardy-Weinberg equilibrium p value
§Fisher exact test
Table 3 Effect of genotypes on demographic and clinical characteristics within PAOG cases
Characteristics Genotypes p valuea
G/G
(n = 22)
No. (%)
G/C
(n = 54)
No. (%)
C/C
(n = 16)
No. (%)
Demographic
Age in years, Mean (SD) 59.0 (13.5) 61.5 (12.0) 60.2 (12.0) 0.713*
Male 14 (25.0) 34 (60.7) 8 (14.2) 0.617
Female 8 (22.2) 20 (55.5) 8 (22.2) -
Medical history
Family history of glaucoma 4 (28.5) 9 (64.2) 1 (7.1) 0.613
Diabetes mellitus 13 (26.5) 28 (57.1) 8 (16.3) 0.813
Smoking 11 (32.3) 17 (50.0) 6 (17.6) 0.316
Hypertension 10 (20.8) 30 (62.5) 8 (16.6) 0.713
Coronary artery disease 2 (28.5) 4 (57.1) 1 (14.2) 0.944
Hypercholesterolemia 5 (33.3) 8 (53.3) 2 (13.3) 0.630
Glaucoma indices
Intraocular pressure in mmHg, Mean (SD) 33.2 (6.2) 34.7 (8.6) 31.9 (5.7) 0.474**
Cup/disc ratio 0.68 (0.19) 0.74 (0.15) 0.64 (0.24) 0.243**
No. of anti-glaucoma medications 2.8 (0.6) 2.8 (0.8) 2.5 (0.6) 0.122**
aChi2 test
*One-way ANOVA
**Kruskal Wallis test
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Genotype effect on demographic and clinical parameters
in POAG
Age (p = 0.713) and gender (p = 0.617) did not show
significant difference between genotypes. Similarly, none
of the systemic diseases and health awareness/behavior
domain variables showed any significant difference.
Importantly, glaucoma specific indices such as IOP, cup/
disc ratio and number of anti-glaucoma medication also
showed no statistically significant difference between the
genotype groups (Table 3).
Besides, logistic regression was performed to ascertain
the effects of age, gender and genotype on the likelihood
of having POAG. However, none of the variables could
significantly explain the likelihood of POAG in this
cohort (Table 4).
Discussion
This study investigated the association between SNP
rs540782, which is in close proximity to ZP4 gene on
chromosome 1, and POAG in the Saudi patients. Previ-
ously this SNP was reported to be associated with
POAG in a group of Japanese patients (p = 0.00006, OR
= 1.34, 95% CI = 1.16–1.54) [4]. However, the authors
did not offer any explanation on how SNP rs540782
contributes to POAG-pathogenesis. Subsequent studies
have failed to establish a link between this SNP and
POAG [6–8]. In our study, the genotype and allele fre-
quencies detected in POAG patients were comparable to
those in controls and thus were insignificant. This is
similar to previous investigations which reported no
association between this SNP and POAG or any of its
clinical indices [6–8]. The minor allele (C) frequency de-
tected in the Saudi population (controls) was 49.4%,
which is similar to the Japanese population’s 49.5% [8],
but higher than that for the Indian (35.6%) [6] and Afro-
Caribbean (29.9%) populations [7].
Association analysis of the genotype effect on clinical
parameters also did not provide any significant link.
None of the systemic diseases and health awareness/be-
havior domain variables such as family history of glau-
coma and smoking showed any significant difference.
Importantly, glaucoma specific indices such as IOP, cup/
disc ratio and number of anti-glaucoma medication also
showed no statistically significant difference between the
genotype groups. Therefore, this SNP, independently or
in relation to other clinical indices, does not have any
effect on POAG development.
Conclusion
This study failed to detect any direct link between geno-
type and allele frequency of SNP rs540782 and POAG or
its related clinical indices, such as IOP and cup/disc
ratio, indicating that this polymorphism is not a risk
factor for POAG in the Saudi cohort.
Abbreviations
CI: Confidence interval; GWAS: Genome-wide association study; HWE: Hardy-
Weinberg Equilibrium; IOP: Intraocular pressure; OR: Odds ratio;
POAG: Primary open angle glaucoma; SNP: Single nucleotide polymorphism;
ZP4: Zona Pellucida Glycoprotein 4
Acknowledgments
The authors would like to thank the Glaucoma Research Chair at the
Department of Ophthalmology, College of Medicine, King Saud University for
funding this study.
Funding
This work was supported by Glaucoma Research Chair at the Department of
Ophthalmology, College of Medicine, King Saud University but had no role
in the design of the study and collection, analysis, and interpretation of data
and in writing the manuscript.
Availability of data and materials
The data supporting the conclusions of this article are all presented within
the article.
Authors’ contributions
AAK: Designed experiments, results, interpretations, manuscript preparation;
NBE: preformed genotyping experiments; HK, ASA: subject recruitment, clinical
examination, clinical data; GM: statistical analysis; SA, TAA, TS: sample collection
and DNA extraction; KAA: study design, overall supervision, results, interpretation,
and preparation of final version of the manuscript. All the authors have approved
the final version of the manuscript.
Competing interests
Authors have no conflict of interests and the work was not supported or
funded by any drug company. The paper has not been presented in any
previous conference or scientific meeting.
Consent for publication
Not applicable.
Ethics approval and consent to participate
The study adhered to the tenets of the Declaration of Helsinki and had
received approval from the Institutional Review Board and Research Ethics
Committee. Written, informed consent was obtained from all participants
prior to their inclusion in this study.
Author details
1Glaucoma Research Chair, Department of Ophthalmology, College of
Medicine, King Saud University, Riyadh 11411, Saudi Arabia. 2Case Western
Reserve University, Ohio, USA. 3SAAD Research & Development Center,
Clinical Research Lab., SAAD Specialist Hospital, P.O. Box 30353, Al Khobar
31952, Saudi Arabia. 4Qassim University, Buraydah, Saudi Arabia. 5Disease
Control Strategy Group, Liverpool School of Tropical Medicine, Liverpool, UK.
6Department of Ophthalmology, College of Medicine, University of Florida,
Jacksonville, FL, USA. 7Ophthalmic Genetics Laboratory, Department of
Ophthalmology, College of Medicine, King Saud University, P.O. Box 245,
Riyadh 11411, Saudi Arabia.
Table 4 Effect of age, sex and genotype on disease outcome
by logistic regression analysis
Variables Odds ratio 95% confidence interval p value
Age 1.02 0.99–1.04 0.103
Sexa 0.59 0.32–1.11 0.104
Genotypeb 0.303
C/G 1.236 0.608–2.51 0.558
C/C 0.727 0.306–1.73 0.471
aFemale as reference
bG/G as reference
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